FDA grants EUA for CPAP filter to make devices safer around healthcare workers

PortPatch (Image from Azimuth Sleep Solutions website)

Azimuth Sleep Solutions announced today that it received FDA emergency use authorization (EUA) for its PortPatch product.

PortPatch, a patent-pending product, is designed to expand air filtration capabilities for patient treatment options and to keep healthcare workers safer in patient care areas in which non-invasive ventilatory treatment devices are in use.

Memphis, Tenn.-based Azimuth Sleep Solutions makes the PortPatch with a hydrophobic, N99-rated filter material to filter out 99% of airborne particulates through exhalation ports, anti-asphyxia valves and carbon dioxide vents on CPAP, BiPAP and other non-invasive ventilation masks, according to a news release.

The company said independent test data for the product showed zero retention of carbon dioxide, while PortPatch also remained in place over vents and ports during tests of low-to-very-high levels of airflow pressures.

PortPatch offe…

Read more
  • 0